[Use of nalidixic acid in infectious diseases of full-term and premature newborn infants].
D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D004926:Escherichia coli / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy*; D007235:Infant, Premature, Diseases / Q000188:drug therapy*; D008111:Liver Function Tests; D008297:Male; D009268:Nalidixic Acid / Q000008:administration & dosage*; D018805:Sepsis / Q000188:drug therapy*
D009268:Nalidixic Acid; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
Uso do "acido nalidíxco" em infecções de recém-nascidos a têrmo e prematuros.